Urologix, Inc. (ULGX) Reports Q3 Loss of $0.07/Share; Revs Improve

April 26, 2012 5:48 PM EDT Send to a Friend
Urologix, Inc. (NASDAQ: ULGX) reported Q3 EPS of ($0.07), versus ($0.07) reported last year. Revenue for the quarter came in at $4.74 million, versus $2.98 million reported last year.

For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment